Contact

Home
About
- About 3D
- 3D Culture System
Services

Druggability Optimization
Drugability Optimization

IND-Enabling
Innovator Drug Generic Drugs Modified New Drug Innovative Veterinary Drug

Pharmacokinetic Study
Basic PK Animal Pretreatment Model PK PK Comparison Ophthalmology Local Administration PK Dermal Patch Application PK

In-vivo Metabolism
Excretion Tissue Distribution CSF Penetration In-vivo Metabolite Identification

Biologics Study
Large Molecule Research

In-vitro ADME Study
Metabolic Stability In-vitro Metabolite Profiling Reaction Phenotyping CYP Induction CYP Inhibition Protein Binding Blood-to-Plasma Ratio Caco-2 Permeability

Bioanalytical Services
Conventional Small Molecules Peptides , XDC and PTOTAC Various Biological Matrices Unstable Compounds , Special Formulations , Endogenous Substances

PKPD Modeling
PBPK PKPD

Oncology
Tumor Cell Activity Assay Metabolic Disease Model Liver Disease Model Metabolic dysfunction-associated steatohepatitis Model Dry Eye Model Collagen Induced Arthritis Rat Mode

Toxicology
Dose Escalating Toxicity Repeat Dosing Toxicity Dose Range Finding Toxicity TK Study

Druggability Optimization
Drugability Optimization

IND-Enabling
Innovator Drug Generic Drugs Modified New Drug Innovative Veterinary Drug

Pharmacokinetic Study
Basic PK Animal Pretreatment Model PK PK Comparison Ophthalmology Local Administration PK Dermal Patch Application PK

In-vivo Metabolism
Excretion Tissue Distribution CSF Penetration In-vivo Metabolite Identification

Biologics Study
Large Molecule Research

In-vitro ADME Study
Metabolic Stability In-vitro Metabolite Profiling Reaction Phenotyping CYP Induction CYP Inhibition Protein Binding Blood-to-Plasma Ratio Caco-2 Permeability

Bioanalytical Services
Conventional Small Molecules Peptides , XDC and PTOTAC Various Biological Matrices Unstable Compounds , Special Formulations , Endogenous Substances

PKPD Modeling
PBPK PKPD

Oncology
Tumor Cell Activity Assay Metabolic Disease Model Liver Disease Model Metabolic dysfunction-associated steatohepatitis Model Dry Eye Model Collagen Induced Arthritis Rat Mode

Toxicology
Dose Escalating Toxicity Repeat Dosing Toxicity Dose Range Finding Toxicity TK Study

View All
News
Contact
Careers

Search

Hot search

Optimization of drug-forming properties2 Optimization of drug-forming properties

EN

简体中文 English

(+86) 0512-6768-3276

business@3dbiooptima.com

1338 Wuzhong Avenue, Suzhou, Jiangsu, China

Media Contacts

Official Public Number: 3D BioOptima

3D BioOptima

3D BioOptima

1338 Wuzhong Avenue, Suzhou, Jiangsu, China

连云港市
用户数:
销量:

泰州市
用户数:4423
销量:8846

镇江市
用户数:4423
销量:8846

南通市
用户数:4423
销量:8846

常州市
用户数:4423
销量:8846

苏州市
用户数:4423
销量:8846

无锡市
用户数:4423
销量:8846

南京市
用户数:4423
销量:8846

淮安市
用户数:4423
销量:8846

扬州市
用户数:4423
销量:8846

宿迁市
用户数:4423
销量:8846

徐州市
用户数:4423
销量:8846

盐城市
用户数:4423
销量:8846

Service Consultation

Please fill out the form below to contact us! Our business specialist will contact you immediately.

If you want to know more about us

You can contact us through the right side, we will assign a professional consultant to answer your questions.

Customer first, customer satisfaction!

Contact Us

Please contact us by filling out the form below! Our customer service will contact you immediately.

Your Name*

Phone*

Please enter your email address

Message

*Sending means that you have agreed to our request《Privacy Policy》。

Customer First, Customer Satisfaction!

Open cooperation

Please contact us by filling out the form below! Our customer service will contact you immediately.

Your Name*

Phone*

Your company name/project name

Cooperation needs*

Message

*Sending means that you have agreed to our request《Privacy Policy》。

Message

Contact Us

Contact us immediately

(+86) 0512-6768-3276

Email

Contact us immediately

business@3dbiooptima.com

Wechat

Wechat

Top